Build engaged audiences through publishing by curation.
Sign up with Facebook
Sign up with Twitter
Sign up with Linkedin
I don't have a Facebook, a Twitter or a LinkedIn account
Start a free trial of Scoop.it Business
US-based Stellar Biotechnologies (Stellar) has entered into an agreement with Taiwan biopharmaceuticals manufacturer Amaran Biotechnology (Amaran) to
Are you sure you want to delete this scoop?
Sunesis Pharmaceuticals has started an investigator-sponsored open label, dose-escalation Phase I/II trial of vosaroxin in combination with azacitidin
Mallinckrodt has reported positive efficacy results from the Phase III clinical trial of MNK-155, an investigational extended-release oral formulation
Mesdames, Messieurs, Je suis heureux, aux côtés d’Eric Le ROY, directeur général du Snitem, de donner le coup d’envoi de ce séminaire c...
FDA Grants Priority Review for Genzyme’s Cerdelga™ , an Investigational Oral Therapy for Gaucher Disease Genzyme, a Sanofi company , announced today
The US Food and Drug Administration (FDA) has awarded orphan drug designation for Dyax's drug candidate DX-2930, a novel, fully human monoclonal antib
L'agence Yoda London, spécialisée dans le référencement et le marketing de contenu, a publié une infographie recensant 33…
Regenx Biosciences and Lysogene have entered into an agreement enabling the development and commercialization of products to treat mucopolysaccharidos
FirstWord Pharma - Gain Access to the Information You Need Track the Companies, Products, and Regulatory Areas of Most Interest to You
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the marketing authorizat
Durata Therapeutics today announced that the New Drug Application (NDA) for its investigational drug, Dalvance (dalbavancin hydrochloride) for injecti
Verastem has started a Phase I trial of a dual mTORC1/2 and PI3K inhibitor 'VS-5584' to treat patients with advanced solid tumors or lymphoma.
CytRx has reported positive top-line efficacy results from a Phase IIb clinical trial, which assessed the efficacy and safety of aldoxorubicin compare
GlaxoSmithKline: le pharmacien qui lave plus blanc
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.
US-based OncoMed Pharmaceuticals has started a Phase Ib clinical trial of its Wnt-pathway-targeting antibody vantictumab (OMP-18R5) in combination wit
DS Healthcare (DSKX) is planning to launch an over-the-counter (OTC) neutraceutical tablet to fight premature hair thinning and improve healthy hair g
Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in
Malgré des dispositifs incitatifs, le développement de médicaments est difficile à rentabiliser dans les maladies rares. Les grands...
GlaxoSmithKline (GSK) has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for m